未登录

H

Homer A. Macapinlac

ut md anderson cancer center

H指数:62

被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis

IF3.3

2024-08-280

OAAI

Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-05-311

OAAI

Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST) a framework for response assessment in bone tumors

IF8.3

2023-08-010

OAAI

A Retrospective Comparative Study of Sodium Fluoride Na18F-PET/CT and 68Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis

IF3.4

2022-11-253

OAAI

18F-Fluciclovine versus PSMA PET Imaging in Primary Tumor Detection during Initial Staging of High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis

RADIOLOGY-IMAGING CANCER

IF6.3

2022-03-016

OA

A Prospective Comparative Study of Using Ultrasonography, 4D-CT and Parathyroid Dual-Phase Scintigraphy with SPECT in Patients with Primary Hyperparathyroidism

IF3.3

2021-10-284

OAAI

What Is the Optimal Method on Myocardial Suppression in FDG PET/CT Evaluation of Cardiac Sarcoidosis?

CLINICAL NUCLEAR MEDICINE

IF9.6

2021-06-163

PRE

18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-04-288

OAAI

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis

IF3.3

2020-12-246

OAAI

Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

CLINICAL CANCER RESEARCH

IF10.2

2020-11-1322

OAAI

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2020-09-0116

OAAI

Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?

CLINICAL NUCLEAR MEDICINE

IF9.6

2020-06-266

PREAI

Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2020-05-0832

OAAI

Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment

CLINICAL NUCLEAR MEDICINE

IF9.6

2020-05-016

PREAI

Nuclear medicine in responding to global pandemic COVID-19-American College of Nuclear Medicine member experience

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2020-04-1512

OAAI

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

3 ′-deoxy-3 ′[(18)F]-氟胸苷 (18F-FLT) PET/CT分子成像对肉瘤靶向治疗早期反应的初步研究

IF3.3

2020-02-255

OAAI

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

CAR转导的自然杀伤细胞在CD19-Positive淋巴肿瘤中的应用

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2020-02-061.4K

OAAI

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT in Lung Cancer

IF3.3

2020-01-0611

OAAI

Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases

PSA阴性前列腺癌骨转移的Superscan 18F-Fluciclovine PET/CT

CLINICAL NUCLEAR MEDICINE

IF9.6

2019-04-017

PREAI

Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST

IF8.3

2019-01-0117

OAAI